PRMT1 promotes epigenetic reprogramming associated with acquired chemoresistance in pancreatic cancer.
Nguyen CDK, Colon-Emeric BA, Murakami S, Shujath MNY, Yi C
Cell Rep. 2024 May 28;43(5):114176. doi: 10.1016/j.celrep.2024.114176. Epub 2024 Apr 30.
(Link opens in a new window)
PubMed
(Link opens in a new window)
Article
Plasmids from Article
No plasmids are currently publicly available from Addgene for this article.